Analystreport

Assertio Therapeutics, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at G.Research, Llc.

Assertio Holdings, Inc.  (ASRT) 
Last assertio holdings, inc. earnings: 3/9 04:02 pm Check Earnings Report